Medication use in normal weight and overweight children in a nationally representative sample of Canadian children
- Correspondence to Dr Paul J Veugelers, School of Public Health, University of Alberta, 350 University Terrace, Edmonton, Alberta, Canada, T6G 2T4;
Contributors SK conducted the analyses and wrote the manuscript. CF contributed to the development of the manuscript. PJV conceived and supervised the study.
- Received 14 October 2011
- Accepted 19 June 2012
- Published Online First 25 July 2012
Background As overweight and obese children are more likely to develop serious medical conditions, they incur higher doctor and hospital costs compared to their normal weight counterparts. Consequently, the differential healthcare costs between obese and normal weight children may be even greater if medication use is considered.
Objective To compare medication use between normal weight and overweight children in a nationally representative sample from Canada.
Methods Data from the Canadian Health Measures Survey 2007/2009, a cross-sectional survey assessing indicators of health and wellness in Canadians, was used in the current study. The analysis included 2087 children and adolescents between 6–19 years of age with valid measures of body mass index (BMI). Poisson/negative binomial regression was used to examine the association between weight status and the number of medications taken in the last month.
Result For 6–11 year olds, the frequency of prescription, over-the-counter and natural health product (NHP) medication use did not differ between normal weight and overweight/obese children. For 12–19 year olds, overweight/obese children used prescription medication significantly more often than their normal weight peers (adjusted incidence rate ratio (IRR), 1.59; 95% CI 1.19 to 2.14), whereas for NHP the opposite was the case (adjusted IRR, 0.52; 95% CI 0.32 to 0.82). These children also used nervous system and respiratory medications more frequently than their normal weight peers.
Conclusion The findings of the present study suggest that the differential usage of prescription drugs among overweight/obese children underline the need to develop effective obesity prevention programmes and policies that may reduce the health and economic burden of childhood obesity.
Funding The research was funded through a Canada Research Chair in Population Health and Alberta Innovates Health Solutions Health Scholarship to PJV.
Disclaimer While the research and analysis are based on CHMS data from Statistics Canada, all interpretations and opinions in the present study are those of the authors and do not represent the views of Statistics Canada.
Competing interests None.
Patient consent Obtained.
Ethics approval Ethics approval obtained from the Health Canada's Research Ethics Board for the CHMS survey and from the Health Research Ethics Board at the University of Alberta for the secondary data analysis in this study.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement This study was based on data from Statistics Canada's CHMS Cycle 1 through a microdata research contract with Statistics Canada. All data are publicly available from the original source.